These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 23146031)
1. Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy. Tomek M; Akiyama T; Dass CR J Pharm Pharmacol; 2012 Dec; 64(12):1695-702. PubMed ID: 23146031 [TBL] [Abstract][Full Text] [Related]
2. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment. Raghav PK; Verma YK; Gangenahalli GU Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216 [TBL] [Abstract][Full Text] [Related]
3. Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells. Shi J; Shen HM Biochem Pharmacol; 2008 May; 75(9):1729-42. PubMed ID: 18377873 [TBL] [Abstract][Full Text] [Related]
4. FKBP38-Bcl-2 interaction: a novel link to chemoresistance. Choi BH; Yoon HS Curr Opin Pharmacol; 2011 Aug; 11(4):354-9. PubMed ID: 21571591 [TBL] [Abstract][Full Text] [Related]
6. Interaction of presenilins with FKBP38 promotes apoptosis by reducing mitochondrial Bcl-2. Wang HQ; Nakaya Y; Du Z; Yamane T; Shirane M; Kudo T; Takeda M; Takebayashi K; Noda Y; Nakayama KI; Nishimura M Hum Mol Genet; 2005 Jul; 14(13):1889-902. PubMed ID: 15905180 [TBL] [Abstract][Full Text] [Related]
7. Dynamic changes of the anti- and pro-apoptotic proteins Bcl-w, Bcl-2, and Bax with Smac/Diablo mitochondrial release after photothrombotic ring stroke in rats. Hu XL; Olsson T; Johansson IM; Brännström T; Wester P Eur J Neurosci; 2004 Sep; 20(5):1177-88. PubMed ID: 15341589 [TBL] [Abstract][Full Text] [Related]
8. Bcl-x(S) can form homodimers and heterodimers and its apoptotic activity requires localization of Bcl-x(S) to the mitochondria and its BH3 and loop domains. Lindenboim L; Borner C; Stein R Cell Death Differ; 2001 Sep; 8(9):933-42. PubMed ID: 11526448 [TBL] [Abstract][Full Text] [Related]
9. Targeting the anti-apoptotic Bcl-2 family members for the treatment of cancer. Weyhenmeyer B; Murphy AC; Prehn JH; Murphy BM Exp Oncol; 2012 Oct; 34(3):192-9. PubMed ID: 23070004 [TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells. Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802 [TBL] [Abstract][Full Text] [Related]
11. Overcoming resistance of cancer cells to apoptosis. Hersey P; Zhang XD J Cell Physiol; 2003 Jul; 196(1):9-18. PubMed ID: 12767037 [TBL] [Abstract][Full Text] [Related]
12. The Bcl-2 family: structures, interactions and targets for drug discovery. Kvansakul M; Hinds MG Apoptosis; 2015 Feb; 20(2):136-50. PubMed ID: 25398535 [TBL] [Abstract][Full Text] [Related]
13. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members. Santiveri CM; Sborgi L; de Alba E J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964 [TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions. Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412 [TBL] [Abstract][Full Text] [Related]
15. The BCL-2 protein family, BH3-mimetics and cancer therapy. Delbridge AR; Strasser A Cell Death Differ; 2015 Jul; 22(7):1071-80. PubMed ID: 25952548 [TBL] [Abstract][Full Text] [Related]
16. Subversion of the Bcl-2 life/death switch in cancer development and therapy. Adams JM; Huang DC; Strasser A; Willis S; Chen L; Wei A; van Delft M; Fletcher JI; Puthalakath H; Kuroda J; Michalak EM; Kelly PN; Bouillet P; Villunger A; O'Reilly L; Bath ML; Smith DP; Egle A; Harris AW; Hinds M; Colman P; Cory S Cold Spring Harb Symp Quant Biol; 2005; 70():469-77. PubMed ID: 16869785 [TBL] [Abstract][Full Text] [Related]
17. How the Bcl-2 family of proteins interact to regulate apoptosis. van Delft MF; Huang DC Cell Res; 2006 Feb; 16(2):203-13. PubMed ID: 16474435 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis in the development and treatment of cancer. Gerl R; Vaux DL Carcinogenesis; 2005 Feb; 26(2):263-70. PubMed ID: 15375012 [TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of FK-506 binding protein 38 and its potential regulatory role on the anti-apoptotic protein Bcl-2. Kang CB; Feng L; Chia J; Yoon HS Biochem Biophys Res Commun; 2005 Nov; 337(1):30-8. PubMed ID: 16176796 [TBL] [Abstract][Full Text] [Related]
20. Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics. Yu L; Liu S Semin Cancer Biol; 2013 Dec; 23(6 Pt B):553-60. PubMed ID: 24012660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]